Pre-Filled Pen
Research use onlyARA-290 16mg / 2mL
VAT included. Shipping calculated at checkout.
In stock
- ≥99% purity
- HPLC & LC-MS analysed
- Stabilised formula
- The world's first brand of peptides in a pen
Secure delivery
Secure delivery with FedEx within 1–2 business days after payment confirmation
Payment methods
- Bank transfer
What is ARA-290?
ARA-290 is a synthetic peptide developed as a short fragment of the erythropoietin (EPO) molecule, but with the unique characteristic that it does not stimulate red blood cell production. Instead, it acts on specific receptors that regulate inflammation, pain perception, and cellular protection.
Scientific interest in ARA-290 is associated with its potential anti-inflammatory, neuroprotective, and regenerative properties. It is the subject of research in immunology, neuroscience, and pain management.
What are the benefits of ARA-290?
1. Anti-inflammatory properties
ARA-290 is being investigated for its ability to reduce inflammation by modulating the immune response. This is particularly important in chronic inflammatory conditions and studies on autoimmune diseases.
2. Neuroprotective effects
ARA-290 may help protect the nervous system by reducing damage caused by inflammation or oxidative stress. This makes it a valuable tool in research models investigating neurodegenerative processes.
3. Pain regulation
One of the most significant potential benefits of ARA-290 is its effect on chronic neuropathic pain. Through its specific receptor mechanisms, the peptide may reduce pain perception without causing the side effects associated with traditional analgesics.
4. Support for cellular regeneration
ARA-290 stimulates cellular mechanisms associated with repair and homeostasis. This is relevant to scientific protocols focused on tissue protection and regeneration.
5. Improvement of metabolic function
The peptide is also being investigated in studies on insulin sensitivity and metabolic balance. This further increases scientific interest in its potential applications in endocrinology.
6. Potential for healthy ageing
The combination of anti-inflammatory, neuroprotective, and metabolic effects makes ARA-290 a promising peptide in research on healthy ageing and the preservation of overall cellular function.
Mechanism of action of ARA-290:
ARA-290 works through interaction with the EPO receptor and the β-common receptor complex – a combination known as the Innate Repair Receptor (IRR). This receptor system is responsible for cellular protection, limiting inflammation, and promoting regenerative processes.
Unlike conventional erythropoietin, ARA-290 does not activate haematopoiesis or increase the number of red blood cells. Instead, it targets mechanisms that reduce inflammation, stimulate regeneration, and minimise damage caused by chronic cellular stress.
This specific mechanism explains the growing scientific interest in ARA-290 in studies on chronic pain, inflammatory diseases, and neurodegeneration.
Proper use and dosage of ARA-290:
Recommended dosage: 30–40 units once daily, administered subcutaneously
1 unit = 80 mcg
Total amount per pen: 200 units (16 mg)
The duration of the cycle may vary depending on the specific condition and individual requirements of the research protocol.
Research on ARA-290 in various fields:
- Neuroscience – investigated for its potential to protect neurons and reduce neuropathic pain.
- Immunology – focusing on its role in regulating inflammatory processes.
- Endocrinology – of interest for its effects on insulin sensitivity and metabolic homeostasis.
- Gerontology – studied in the context of supporting healthy ageing.
- Molecular biology – analysed for its interaction with the Innate Repair Receptor and its effects on gene expression.
- Rehabilitation – investigated as a tool for supporting recovery following cellular damage.
Possible side effects of ARA-290:
ARA-290 is generally considered well tolerated in research settings. Reports of side effects are rare and usually mild:
- Mild redness or discomfort at the injection site.
- Headaches – short-lasting and mild in intensity.
- Fatigue – temporary changes in energy levels.
- Mild sleep disturbances – rare and temporary.
- Changes in appetite – usually mild and short-term.
Overall, the available data suggest that ARA-290 has a favourable tolerability profile and represents a valuable tool in research protocols focused on inflammation, neuroprotection, and chronic pain.












